The Clinical Findings Useful for Driving Safety Advice for Parkinson's Disease Patients

Internal Medicine
Rina AndoParkinson's Disease Safe Driving Study Group of Japan

Abstract

Objective We conducted a study to obtain information that could be used to provide Parkinson's disease (PD) patients with appropriate advice on safe driving. Methods Consecutive PD patients who visited our office were studied. Among these patients, those who had experienced driving after being diagnosed with PD were interviewed by neurologists and a trained nurse to investigate their previous car accidents, motor function, cognitive function, sleepiness, levodopa equivalent dose (LED), and emotional dysregulation. The rates of major car accidents before and after the onset of PD were compared. Results Fifteen patients had experienced a major car accident resulting in human injury or serious property damage since the onset of PD. When the rates of major car accidents before and after the onset of PD were compared, the ratio was 4.3 [95% confidence interval (CI) 1.9-9.7]. The incidence of accidents after the onset of PD was correlated with age, disease duration, LED, the cognitive function Mini-Mental Scale Examination (MMSE), Japanese translation of the Montreal Cognitive Assessment (MoCA-J), but not the motor symptom score [Unified Pankinson's disease rating scale (UPDRS) part III at the time of the study]. The Questionnaire fo...Continue Reading

References

Apr 1, 1991·Neurology·R M DubinskyW C Koller
Jul 1, 1990·Journal of Neurology, Neurosurgery, and Psychiatry·P MadeleyR H Mindham
Apr 4, 1998·Journal of Neurology, Neurosurgery, and Psychiatry·V M HeikkiläH Summala
Sep 14, 2006·Annals of Neurology·Ergun Y UcJeffrey D Dawson
Nov 18, 2006·Journal of the Neurological Sciences·M M AmickB R Ott
Apr 14, 2010·Neurology·D J IversonUNKNOWN Quality Standards Subcomittee of the American Academy of Neurology
Nov 12, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Claire L TomlinsonCarl E Clarke
Nov 15, 2012·Neurology·Alexander M CrizzleErgun Y Uc
Apr 16, 2013·Internal Medicine·Win Thiri KyawMasahiro Nomoto
Oct 12, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Maud RanchetEmmanuel Broussolle
Oct 24, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Sherrilene Classen, Jeffrey Holmes
Oct 30, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Hannes DevosErgun Y Uc
Dec 26, 2013·The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association·Sherrilene ClassenNikolaus R McFarland
Jan 8, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Michele T M HuYoav Ben-Shlomo
Feb 7, 2014·International Journal of General Medicine·Tomoaki TujiiMasahiro Nomoto
May 20, 2015·Journal of Neurology, Neurosurgery, and Psychiatry·Patrick EsserHelen Dawes
Jun 24, 2015·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·Renerus J StolwykNellie Georgiou-Karistianis
Sep 17, 2015·Traffic Injury Prevention·Sophia VardakiSokratis G Papageorgiou

❮ Previous
Next ❯

Software Mentioned

SAS JMP

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.